PF-03382792

• Description:

  PF-03382792 (PF-3382792) is a clinical compound under phase 1 investigation for an unknown indication.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  433.52

• Molecular Formula:

  C23H32FN3O4

• Notes:

  Research use only, not for human use.

• Receptor:

  Other Targets

• CAS Number:

  1400811-63-3